1. Huang, Danna, Chen, Lu, Liu, Yu, Liu, Yingying, Pan, Yu. 2024. Knockdown of Anoikis-Associated Gene OCIAD2 Reduces Proliferation and Migration of Glioblastoma Cell Lines. In Combinatorial chemistry & high throughput screening, , . doi:10.2174/0113862073305357240719070044. https://pubmed.ncbi.nlm.nih.gov/39076095/
2. Yin, Yi-Fan, Jia, Qin-Yuan, Yao, Hong-Fei, Huo, Yan-Miao, Liu, Wei. 2024. OCIAD2 promotes pancreatic cancer progression through the AKT signaling pathway. In Gene, 927, 148735. doi:10.1016/j.gene.2024.148735. https://pubmed.ncbi.nlm.nih.gov/38944166/
3. Hong, Jeongmin, Shiba-Ishii, Aya, Kim, Yunjung, Noguchi, Masayuki, Sakamoto, Noriaki. 2021. Ovarian carcinoma immunoreactive antigen domain 2 controls mitochondrial apoptosis in lung adenocarcinoma. In Cancer science, 112, 5114-5126. doi:10.1111/cas.15160. https://pubmed.ncbi.nlm.nih.gov/34628698/
4. Maki, Masahiro, JeongMin, Hong, Nakagawa, Tomoki, Sato, Yukio, Noguchi, Masayuki. 2022. Aberrant OCIAD2 demethylation in lung adenocarcinoma is associated with outcome. In Pathology international, 72, 496-505. doi:10.1111/pin.13262. https://pubmed.ncbi.nlm.nih.gov/35920378/
5. Yang, Zibing, Ouyang, Tao, Aoyagi, Haruyo, Li, Sha, Kong, Lingbao. 2021. Cellular OCIAD2 protein is a proviral factor for hepatitis C virus replication. In International journal of biological macromolecules, 188, 147-159. doi:10.1016/j.ijbiomac.2021.08.032. https://pubmed.ncbi.nlm.nih.gov/34371038/
6. Kamat, Kajal, Inamdar, Maneesha S. 2023. Generation of OCIAD2 homozygous knockout (BJNhem20-OCIAD2-CRISPR-33) and heterozygous knockout (BJNhem20-OCIAD2-CRISPR-40) human embryonic stem cell lines using CRISPR-Cas9 mediated targeting. In Stem cell research, 67, 103026. doi:10.1016/j.scr.2023.103026. https://pubmed.ncbi.nlm.nih.gov/36642056/
7. Chojnacka, Katarzyna Justyna, Elancheliyan, Praveenraj, Mussulini, Ben Hur Marins, Serwa, Remigiusz Adam, Chacinska, Agnieszka. 2022. Ovarian carcinoma immunoreactive antigen-like protein 2 (OCIAD2) is a novel complex III-specific assembly factor in mitochondria. In Molecular biology of the cell, 33, ar29. doi:10.1091/mbc.E21-03-0143. https://pubmed.ncbi.nlm.nih.gov/35080992/
8. Zhang, Rengjing, Zhao, Chen, Xiong, Zixiang, Zhou, Xiaobo. 2014. Pathway bridge based multiobjective optimization approach for lurking pathway prediction. In BioMed research international, 2014, 351095. doi:10.1155/2014/351095. https://pubmed.ncbi.nlm.nih.gov/24949437/
9. Wu, Dan, Yang, Xufang, Peng, Huiming, Zhao, Chen, Zhou, Xiaobo. . OCIAD2 suppressed tumor growth and invasion via AKT pathway in Hepatocelluar carcinoma. In Carcinogenesis, 38, 910-919. doi:10.1093/carcin/bgx073. https://pubmed.ncbi.nlm.nih.gov/28911005/